Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation

Abstract

Aims/hypothesis Beta cell death triggered by pro-inflammatory cytokines plays a central role in the pathogenesis of type 1 diabetes and loss of transplanted islets. The nuclear factor κB (NF-κB) signalling pathway is a key regulator of beta cell stress response, survival and apoptosis. Withaferin A (WA), a steroidal lactone derived from Withania somnifera, has been demonstrated to be a potent, safe, anti-inflammatory molecule that can inhibit NF-κB signalling. Therefore, we evaluated the ability of WA to protect mouse and human islets from the damaging effects of pro-inflammatory cytokines in vitro and following intraportal transplantation. Methods Mouse and human islets were treated with a cytokine cocktail, and NF-κB activation was measured by immunoblots, p65 nuclear translocation and chromatin immunoprecipitation of p65-bound DNA. Intraportal transplantation of a marginal mass of syngeneic mouse islets was performed to evaluate the in vivo protective effect of WA. Results Treatment with WA substantially improved islet engraftment of syngeneic islets (83% for infusion with 200 islets + WA; 0% for 200 islets + vehicle) in a mouse model of diabetes, compared with marginal graft controls with superior islet function in WA-treated mice confirmed by glucose tolerance test. Treatment of human and mouse islets with WA prevented cytokine-induced cell death, inhibited inflammatory cytokine secretion and protected islet potency. Conclusions WA was shown to be a strong inhibitor of the inflammatory response in islets, protecting against cytokineinduced cell damage while improving survival of transplanted islets. These results suggest that WA could be incorporated as an adjunctive treatment to improve islet transplant outcome.

Overexpression of MicroRNA-25 by Withaferin A Induces Cyclooxygenase-2 Expression in Rabbit Articular Chondrocytes

“…In the previous studies, treatment of WFA inhibited inflammatory cytokine secretion in human and mouse islets (27). Also, WFA inhibited inflammation via inhibition of NO production and iNOS expression by blocking Akt and subsequently down-regulating NF-kB activity in RAW 264.7, a mouse leukemic monocyte macrophage cell line (28).…”

Hypoglycemic activity of withanolides and elicitated Withania somnifera

“…Results are averages ± SE of 5 individual biological repeats. cells and protecting against cytokine induced damage (Peng et al, 2010;SoRelle et al, 2013), the role of withaferin A as an insulin mimetic is quite novel. In addition, W. somnifera's insulin secretagogue activity is also surprising.…”

Withania somnifera shows ability to counter Parkinson's Disease: An Update

“…Kobuyama T et al,2002 [32] illustrated therapeutic potential of withanolide A isolated from root of Ws, that possess ability to regenerate neurites and reconstruct synapses in severly damaged neurons in mice. Amongst withanolides of Ws, withaferin A, a major component of biologically active steroids, showed potent anti-inflammatory [33] and anti-cancerous activity [34]. Thus, the study revealed the pharmacological potential of Ws, which could be harnessed in future, for the therapeutic approaches to PD.…”